Name | (2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-phenylpropanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]propanoic acid |
---|---|
Synonyms |
TCS JNK 6o
L-Alanine,L-phenylalanylglycylglycyl-L-phenylalanyl-L-threonylglycyl |
Description | Nociceptin (1-7) is the N-terminal bioactive fragment of nociceptin (HY-P0183). Nociceptin (1-7) is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) combines with nociceptin reduces hyperalgesia in vivo[1]. |
---|---|
Related Catalog | |
In Vivo | Nociceptin (1-7) (intrathecal injection; 150–1200 nmol; single dose) has no significant effect in the nociceptive thermal threshold (hyperalgesia). However, when nociceptin (1–7) is injected simultaneously with nociceptin (3.0 fmol), nociceptin-induced hyperalgesia is significantly reduced[1]. Animal Model: Mice[1] Dosage: 150–1200 nmol Administration: Intrathecal injection; single dose Result: Co-treatment with nociceptin could reduce hyperalgesia. |
References |
Molecular Formula | C31H41N7O9 |
---|---|
Molecular Weight | 655.69900 |
Exact Mass | 655.29700 |
PSA | 279.09000 |
LogP | 2.82950 |